Global Lung Cancer Diagnostics Market

Global Lung Cancer Diagnostics Market

Global Lung Cancer Diagnostics Market

The global lung cancer diagnostics market is expected to generate revenue of US$3.32 bn by end of 2025, growing at a CAGR of around 7.9% between 2019 and 2025.

SUITE N202, NEW YORK, UNITED STATES, October 10, 2022 /EINPresswire.com/ -- Zion Market Research has published a new report titled “Lung Cancer Diagnostics Market by Type (Non-small Cell Lung Cancer and Small Cell Lung Cancer) and Test (Biopsy, Imaging Test, Molecular Test, Sputum Cytology, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025” According to the report, global demand for lung cancer diagnostics market was valued at approximately USD 1.96 billion in 2018, and is expected to generate revenue of around USD 3.32 billion by end of 2025, growing at a CAGR of around 7.9% between 2019 and 2025.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑭𝒓𝒆𝒆 𝑺𝒂𝒎𝒑𝒍𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 𝒐𝒇 @ https://www.zionmarketresearch.com/sample/lung-cancer-diagnostics-market

Lung cancer is a type of cancer which starts in the lungs. Lungs execute a vital task of taking in oxygen and discharging carbon dioxide. Lung cancer is the predominant cause of cancer demises worldwide. Cigarette smoking is a key factor that can lead to lung cancer. Passive smoking also leads to development of lung cancer in non-smokers. Other causes of lung cancer are exposure to asbestos fibers and radon gas. Non-small cell lung cancer and small cell lung cancer are the two types of lung cancer. As per statistics from the American Cancer Society, there will be about 228,000 new cases of lung cancer in the U.S. in 2019. Tests like chest x-ray, CT scan, MRI, PET scan, sputum cytology, bone scan, and biopsy are performed to diagnose lung cancer.

Factors such as development of biomarkers specific to lung cancer, high number of awareness programs undertaken by government and non-governmental organizations, efforts taken to increase the diagnosis and screening rates of lung cancer, heavy use of tobacco in some regions, and technological advancements will act as major driving factors in the growth of global lung cancer diagnostics market. Strong pipeline of biomarkers and favorable government policies in developing regions will act as an opportunity for the market players in the lung cancer diagnostics market. Nonetheless, dearth of skilled personnel, and lack of awareness regarding early screening of lung cancer in low income countries will restrict the growth of global lung cancer diagnostics market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭 𝐇𝐄𝐑𝐄

The global lung cancer diagnostics market has been split into type, test. Based on type, lung cancer diagnostics market has been segmented into non-small cell lung cancer and small cell lung cancer. The non-small cell lung cancer segment accounted for the highest market share in 2018 due to accessibility of new lung cancer diagnostics that enable the detection of big tumor developments.

The test segment has been segmented into biopsy, imaging test, molecular test, sputum cytology, and others. The imaging test segment accounted for the highest market share in 2018 due to repeated use of imaging techniques like x-ray, CT, and MRI.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America will be the leading region during the forecast period. Development of technology-enabled diagnostics, presence of leading market players, and rapid uptake of new technologies will boost the market growth in this region. Europe will be the second largest market.

The key reasons are existence of skilled researchers, increase in awareness about early screening of lung cancer, and favorable reimbursement scenario. Asia Pacific will propagate at speedy rate over the forecast period due to increasing cases of lung cancer due to heavy use of tobacco and efforts taken by various agencies to create awareness regarding early diagnosis of lung cancer.

Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.

Browse Press Release @ https://www.zionmarketresearch.com/news/lung-cancer-diagnostics-market

The report also includes detailed profiles of key players such as

Roche Diagnostics
bioMérieux
Thermo Fisher Scientific
Illumina Inc.
Qiagen N.V.
Agilent Technologies
Sanofi S.A.
AstraZeneca plc
Janssen among others.

Objectives of the Study:

• To provide an exhaustive analysis on the Lung Cancer Diagnostics Market By Resin Type, By Backing Material, By Application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, and the rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers, and expansions

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 - https://www.zionmarketresearch.com/inquiry/lung-cancer-diagnostics-market

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐬

1. North America (U.S., Canada)
2. Latin America (Mexico, Brazil)
3. Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
4. Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
5. Asia Pacific Excluding Japan (China, India, ASEAN, JAPAN, Australia & New Zealand)
6. the Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒

1) What was the value of the global Lung Cancer Diagnostics Market in 2020?
2) What will be the size of the global Lung Cancer Diagnostics Market in 2028?
3) What are the key factors driving the global Lung Cancer Diagnostics Market growth?
4) Which region will make notable contributions to the global Lung Cancer Diagnostics Market?
5) Who are the major companies operating in the global Lung Cancer Diagnostics Market?

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑫𝒊𝒔𝒄𝒐𝒖𝒏𝒕 𝒐𝒏 𝑻𝒉𝒊𝒔 𝑹𝒆𝒑𝒐𝒓𝒕:

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 –

The long-term consequences of COVID-19 are expected to have a negative influence on industry growth over the predicted period, making it an unprecedented worldwide public health emergency. As we continue to dig further into the challenges surrounding COVID-19, we are better able to identify possible solutions. Consumer demand, purchasing habits, supply chain rerouting, current market factors, and substantial government initiatives are all examined in the report on COVID-19.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐙𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 –

Global Liquid Biopsy Market - https://www.einnews.com/pr_news/589564770/global-liquid-biopsy-market-report-size-growth-share-at-a-cagr-of-around-38-3-by-2028-forcaste-analysis-by-zmr

3D Bioprinting Market - https://www.einnews.com/pr_news/594116100/3d-bioprinting-market-increasing-demand-for-organ-transplantation-and-aging-population-drives-the-market-by-2022-2028

Global Healthcare Electronic Data Interchange (EDI) Market - https://www.einnews.com/pr_news/593916523/global-healthcare-electronic-data-interchange-edi-market-analysis-to-accounted-for-value-around-usd-925-0-mn-by-2025

Anastomosis Device Market - https://www.zionmarketresearch.com/report/anastomosis-device-market

Acute Kidney Injury Treatment Market - https://www.zionmarketresearch.com/report/acute-kidney-injury-treatment-market

Global Burn Injury Treatment Market - https://www.linkedin.com/pulse/global-burn-injury-treatment-market-report-types-players-maria-howard/

Cellulose Acetate Market - https://www.openpr.com/news/2760533/global-cellulose-acetate-market-size-share-growth-trends

Kavita More
Zion Market Research
+1 855-465-4651
Kavita.m@marketresearchstore.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Other